APO RESEARCH · REPORT
Pressurized Metered Dose Inhaler
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
Product & engineering
Understand the product.
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
Selected research
Market Structure
Global Pressurized Metered Dose Inhaler Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
Read the full market overview
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report provides an overview of the global Pressurized Metered Dose Inhaler market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pressurized Metered Dose Inhaler and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pressurized Metered Dose Inhaler sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pressurized Metered Dose Inhaler market size, projected growth trends, production technologies, key applications, and end-use industries.
Pressurized Metered Dose Inhaler Segment by Company
GlaxoSmithKline
Chiesi Farmaceutici S.p.A
AstraZeneca
Teva
Merck & Co. Inc
Boehringer Ingelheim
Mylan
Arkon
Pressurized Metered Dose Inhaler Segment by Type
Manual Pressurized Metered Dose Inhaler
Smart Pressurized Metered Dose Inhaler
Pressurized Metered Dose Inhaler Segment by Application
Asthma
COPD
Others
Pressurized Metered Dose Inhaler Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pressurized Metered Dose Inhaler market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pressurized Metered Dose Inhaler and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pressurized Metered Dose Inhaler.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pressurized Metered Dose Inhaler market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pressurized Metered Dose Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pressurized Metered Dose Inhaler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pressurized Metered Dose Inhaler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Manual Pressurized Metered Dose Inhaler
- Smart Pressurized Metered Dose Inhaler
Applications
- Asthma
- COPD
- Others
Companies covered
- GlaxoSmithKline
- Chiesi Farmaceutici S.p.A
- AstraZeneca
- Teva
- Merck & Co. Inc
- Boehringer Ingelheim
- Mylan
- Arkon
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pressurized Metered Dose Inhaler Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pressurized Metered Dose Inhaler Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pressurized Metered Dose Inhaler Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pressurized Metered Dose Inhaler Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pressurized Metered Dose Inhaler Market Dynamics
- 2.1 Pressurized Metered Dose Inhaler Industry Trends
- 2.2 Pressurized Metered Dose Inhaler Industry Drivers
- 2.3 Pressurized Metered Dose Inhaler Industry Opportunities and Challenges
- 2.4 Pressurized Metered Dose Inhaler Industry Restraints
3 Pressurized Metered Dose Inhaler Market by Manufacturers
- 3.1 Global Pressurized Metered Dose Inhaler Revenue by Manufacturers (2021-2026)
- 3.2 Global Pressurized Metered Dose Inhaler Sales by Manufacturers (2021-2026)
- 3.3 Global Pressurized Metered Dose Inhaler Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pressurized Metered Dose Inhaler Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pressurized Metered Dose Inhaler Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pressurized Metered Dose Inhaler Manufacturers, Product Type & Application
- 3.7 Global Pressurized Metered Dose Inhaler Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pressurized Metered Dose Inhaler Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pressurized Metered Dose Inhaler Players Market Share by Revenue in 2025
- 3.8.3 2025 Pressurized Metered Dose Inhaler Tier 1, Tier 2, and Tier 3
4 Pressurized Metered Dose Inhaler Market by Type
- 4.1 Pressurized Metered Dose Inhaler Type Introduction
- 4.1.1 Manual Pressurized Metered Dose Inhaler
- 4.1.2 Smart Pressurized Metered Dose Inhaler
- 4.2 Global Pressurized Metered Dose Inhaler Sales by Type
- 4.2.1 Global Pressurized Metered Dose Inhaler Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pressurized Metered Dose Inhaler Sales by Type (2021-2032)
- 4.2.3 Global Pressurized Metered Dose Inhaler Sales Market Share by Type (2021-2032)
- 4.3 Global Pressurized Metered Dose Inhaler Revenue by Type
- 4.3.1 Global Pressurized Metered Dose Inhaler Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pressurized Metered Dose Inhaler Revenue by Type (2021-2032)
- 4.3.3 Global Pressurized Metered Dose Inhaler Revenue Market Share by Type (2021-2032)
5 Pressurized Metered Dose Inhaler Market by Application
- 5.1 Pressurized Metered Dose Inhaler Application Introduction
- 5.1.1 Asthma
- 5.1.2 COPD
- 5.1.3 Others
- 5.2 Global Pressurized Metered Dose Inhaler Sales by Application
- 5.2.1 Global Pressurized Metered Dose Inhaler Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pressurized Metered Dose Inhaler Sales by Application (2021-2032)
- 5.2.3 Global Pressurized Metered Dose Inhaler Sales Market Share by Application (2021-2032)
- 5.3 Global Pressurized Metered Dose Inhaler Revenue by Application
- 5.3.1 Global Pressurized Metered Dose Inhaler Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pressurized Metered Dose Inhaler Revenue by Application (2021-2032)
- 5.3.3 Global Pressurized Metered Dose Inhaler Revenue Market Share by Application (2021-2032)
6 Global Pressurized Metered Dose Inhaler Sales by Region
- 6.1 Global Pressurized Metered Dose Inhaler Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pressurized Metered Dose Inhaler Sales by Region (2021-2032)
- 6.2.1 Global Pressurized Metered Dose Inhaler Sales by Region (2021-2026)
- 6.2.2 Global Pressurized Metered Dose Inhaler Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pressurized Metered Dose Inhaler Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pressurized Metered Dose Inhaler Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pressurized Metered Dose Inhaler Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pressurized Metered Dose Inhaler Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pressurized Metered Dose Inhaler Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pressurized Metered Dose Inhaler Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pressurized Metered Dose Inhaler Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pressurized Metered Dose Inhaler Revenue by Region
- 7.1 Global Pressurized Metered Dose Inhaler Revenue by Region
- 7.1.1 Global Pressurized Metered Dose Inhaler Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pressurized Metered Dose Inhaler Revenue by Region (2021-2026)
- 7.1.3 Global Pressurized Metered Dose Inhaler Revenue by Region (2027-2032)
- 7.1.4 Global Pressurized Metered Dose Inhaler Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pressurized Metered Dose Inhaler Revenue (2021-2032)
- 7.2.2 North America Pressurized Metered Dose Inhaler Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pressurized Metered Dose Inhaler Revenue (2021-2032)
- 7.3.2 Europe Pressurized Metered Dose Inhaler Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pressurized Metered Dose Inhaler Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pressurized Metered Dose Inhaler Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pressurized Metered Dose Inhaler Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pressurized Metered Dose Inhaler Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 GlaxoSmithKline
- 8.1.1 GlaxoSmithKline Company Information
- 8.1.2 GlaxoSmithKline Business Overview
- 8.1.3 GlaxoSmithKline Pressurized Metered Dose Inhaler Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 GlaxoSmithKline Pressurized Metered Dose Inhaler Product Portfolio
- 8.1.5 GlaxoSmithKline Recent Developments
- 8.2 Chiesi Farmaceutici S.p.A
- 8.2.1 Chiesi Farmaceutici S.p.A Company Information
- 8.2.2 Chiesi Farmaceutici S.p.A Business Overview
- 8.2.3 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Product Portfolio
- 8.2.5 Chiesi Farmaceutici S.p.A Recent Developments
- 8.3 AstraZeneca
- 8.3.1 AstraZeneca Company Information
- 8.3.2 AstraZeneca Business Overview
- 8.3.3 AstraZeneca Pressurized Metered Dose Inhaler Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 AstraZeneca Pressurized Metered Dose Inhaler Product Portfolio
- 8.3.5 AstraZeneca Recent Developments
- 8.4 Teva
- 8.4.1 Teva Company Information
- 8.4.2 Teva Business Overview
- 8.4.3 Teva Pressurized Metered Dose Inhaler Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Teva Pressurized Metered Dose Inhaler Product Portfolio
- 8.4.5 Teva Recent Developments
- 8.5 Merck & Co. Inc
- 8.5.1 Merck & Co. Inc Company Information
- 8.5.2 Merck & Co. Inc Business Overview
- 8.5.3 Merck & Co. Inc Pressurized Metered Dose Inhaler Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Merck & Co. Inc Pressurized Metered Dose Inhaler Product Portfolio
- 8.5.5 Merck & Co. Inc Recent Developments
- 8.6 Boehringer Ingelheim
- 8.6.1 Boehringer Ingelheim Company Information
- 8.6.2 Boehringer Ingelheim Business Overview
- 8.6.3 Boehringer Ingelheim Pressurized Metered Dose Inhaler Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Boehringer Ingelheim Pressurized Metered Dose Inhaler Product Portfolio
- 8.6.5 Boehringer Ingelheim Recent Developments
- 8.7 Mylan
- 8.7.1 Mylan Company Information
- 8.7.2 Mylan Business Overview
- 8.7.3 Mylan Pressurized Metered Dose Inhaler Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Mylan Pressurized Metered Dose Inhaler Product Portfolio
- 8.7.5 Mylan Recent Developments
- 8.8 Arkon
- 8.8.1 Arkon Company Information
- 8.8.2 Arkon Business Overview
- 8.8.3 Arkon Pressurized Metered Dose Inhaler Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Arkon Pressurized Metered Dose Inhaler Product Portfolio
- 8.8.5 Arkon Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pressurized Metered Dose Inhaler Value Chain Analysis
- 9.1.1 Pressurized Metered Dose Inhaler Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pressurized Metered Dose Inhaler Production Mode & Process
- 9.2 Pressurized Metered Dose Inhaler Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pressurized Metered Dose Inhaler Distributors
- 9.2.3 Pressurized Metered Dose Inhaler Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst